Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults (Q89273580)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Tejal Shah

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Ralph Martins

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Stephanie R Rainey-Smith

series ordinal

1

object named as

Stephanie R Rainey-Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

2

Belinda M Brown

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

6

Veer B Gupta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

5

Kathryn G Goozee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

22 April 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Nutrition

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

2106-2113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin: the Indian solid gold

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin, inflammation, ageing and age-related diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Antidepressant activity of curcumin: involvement of serotonin and dopamine system

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Development of the Cambridge Contextual Reading Test for improving the estimation of premorbid verbal intelligence in older persons with dementia

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

The promise of slow down ageing may come from curcumin.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin alters the salt bridge-containing turn region in amyloid β(1-42) aggregates.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Protective effects of curcumin on amyloid-β-induced neuronal oxidative damage

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curry consumption and cognitive function in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Subtle memory decline over 12 months in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Prospective and retrospective memory in normal ageing and dementia: a questionnaire study.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin ameliorates memory deficits via neuronal nitric oxide synthase in aged mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories

1 reference

https://api.crossref.org/works/10.1017%2FS0007114516001203

7 January 2021

10.1017/S0007114516001203

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27102361%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference